Forensic aspects related to pediatric pathology--Medicolegal aspects of pediatric head injuries

Roger W Byard1

  • 1Disciline of Pathology, University of Adelaide, Adelaide, Australia. byard.roger@saugov.sa.gov.au

Insights

Diagnosing inflicted head injuries in young children is challenging due to subtle signs and limited research. This review addresses medicolegal evaluation difficulties for craniocerebral trauma in these cases.

Area of Science:

  • Pediatric Pathology
  • Forensic Medicine
  • Child Abuse Research

Background:

  • Assessing inflicted head injuries in infants and children presents diagnostic challenges.
  • Subtle injury presentation, non-specific lesions, and limited experimental data complicate evaluations.
  • Lack of literature and individual experience further hinders accurate assessment.

Purpose of the Study:

  • To review the complexities in the medicolegal evaluation of inflicted craniocerebral trauma in young children.
  • To identify and discuss issues arising in legal proceedings related to these injuries.

Main Methods:

  • Literature review of existing studies on pediatric head injuries.
  • Analysis of challenges in pathological examination and force assessment.
  • Discussion of medicolegal and court-related issues.

Main Results:

  • Pathological assessment is often complicated by subtle injury indicators.
  • Non-specific lesions and scarcity of data on injury mechanisms pose significant hurdles.
  • Insufficient literature and experience impact expert opinions.

Conclusions:

  • Medicolegal evaluation of inflicted head trauma in children faces considerable obstacles.
  • These challenges lead to complexities and disputes in court proceedings.
  • Further research is needed to clarify injury mechanisms and improve diagnostic accuracy.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...